The Cebpa Downstream Enhancer as a Key Target of Transformation to Acute Myeloid Leukemia |
The Johns Hopkins University School of Medicine / Stacy Cooper, MD |
Young Investigator Grants |
2015 |
Maryland |
Hedgehog & IGF Signaling through IRSI in Brain Development and Medulloblastoma
|
Memorial Sloan-Kettering Cancer Center / Anna Marie Kenney, PhD |
Young Investigator Grants |
2006 |
New York |
Identification of Synthetically Immunogenic Compounds to Synergize with Immunotherapy in Neuroblastoma |
Children’s Hospital of Philadelphia / Adam Wolpaw, MD/PhD |
Young Investigator Grants |
2019 |
Pennsylvania |
Micro-environmental Regulators of Ewing sarcoma Metastasis |
University of Pittsburgh / Kelly Bailey, MD/PhD |
Young Investigator Grants |
2016 |
Pennsylvania |
Identifying Disease Mechanisms and Therapeutic Opportunities in Pediatric Low-grade Gliomas Driven by MYB-QKI Fusions |
Dana-Farber Cancer Institute / Cecile Rouleau, PhD |
Young Investigator Grants |
2017 |
Massachusetts |
An Exploration of the Medulloblastoma and Glioblastoma Genomes: A Critical Analysis of Candidate Cancer Genes as Potential Molecular Targets for Diagnostics and Therapeutics
|
The Johns Hopkins University School of Medicine / Will Parsons, MD, PhD |
Young Investigator Grants |
2007 |
Maryland |
Enhancing the therapeutic efficacy of chimeric antigen receptor T cells for acute myeloid leukemia |
Washington University / Miriam Kim, MD |
Young Investigator Grants |
2019 |
Missouri |
Role of N6-Methyladenosine (m6A) mRNA Modification Pathway in Neuroblastoma |
Boston Children’s Hospital / Shuibin Lin, PhD |
Young Investigator Grants |
2017 |
Massachusetts |
Small-molecule screening for novel pediatric glioma radiosensitizers. |
Yale School of Medicine / Ranjit Bindra |
Young Investigator Grants |
2012 |
Connecticut |
Histone Modification and Hmgn1 Overexpression as Drivers of B-ALL with Polysomy 21 |
Dana-Farber Cancer Institute / Andrew Lane, MD, PhD |
Young Investigator Grants |
2013 |
Massachusetts |